INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, vol.75, no.3, 2021 (SCI-Expanded)
Background Vitiligo is an autoimmune disease characterised by acquired loss of melanocytes. Although the pathogenesis of vitiligo remains unknown, oxidative stress and autoimmune dysregulations are considered to play a role.